Pregled bibliografske jedinice broj: 297765
Irinotecan toxicity to human blood cells in vitro – relationships between various biomarkers
Irinotecan toxicity to human blood cells in vitro – relationships between various biomarkers // Basic&Clinical Pharmacology&Toxicology, 100 (2007), 6; 403-413 doi:10.1111/j.1742-7843.2007.00068.x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 297765 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Irinotecan toxicity to human blood cells in vitro – relationships between various biomarkers
Autori
Kopjar, Nevenka ; Želježić, Davor ; Lucić Vrdoljak, Ana ; Radić, Božica ; Ramić, Snježana ; Milić, Mirta ; Gamulin, Marija ; Pavlica, Vesna ; Fučić, Aleksandra
Izvornik
Basic&Clinical Pharmacology&Toxicology (1742-7835) 100
(2007), 6;
403-413
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
irinotecan; in vitro toxicity; AChE; genotoxicity; comet assay test
Sažetak
Toxic effects of the antineoplastic drug irinotecan on human blood cells at concentrations 9.0 μ g/ml and 4.6 μ g/ml were evaluated in vitro. Using the alkaline and neutral comet assay significantly increased levels of primary DNA damage in lymphocytes were detected. The induction of apoptosis/necrosis, as determined by a fluorescent assay, was also notably increased. Cytogenetic outcomes of the treatment were assessed by the analysis of structural chromosome aberrations and FISH. Significantly higher incidence of chromatid breaks and complex quadriradials was observed. Painted chromosomes 1, 2, and 4 were equally involved in translocations, but only the chromosome 1 was involved in formation of quadriradials. SCE analysis was performed in parallel with the analysis of lymphocyte proliferation kinetics. The higher concentration of irinotecan caused almost seven-fold, while the lower one caused a five-fold increase of the basal SCE frequency, accompanied with significant lowering of the lymphocyte proliferation index. Using the cytokinesis-block micronucleus (MN) assay, a dose-dependent increase in MN frequency along with the formation of nuclear buds and nucleoplasmic bridges was noticed. Inhibitory effects of irinotecan on enzyme acetylcholinesterase (AChE) were studied in erythrocytes. An IC50 value of 5.0 x 10-7 was established. Irinotecan was found to be strong inhibitor of the ACh hydrolysis and caused a continuous decrease of catalytic activity of AChE. The results obtained on a single donor may contribute to the understanding of irinotecan toxicity, but further in vitro and in vivo studies are essential in order to clarify remaining issues, especially on possible inter-individual variability in genotoxic responses to the drug.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
022-0222148-2137 - Genotoksičnost kemijskih i fizikalnih agensa prirodnog i antropogenog podrijetla (Kašuba, Vilena, MZOS ) ( CroRIS)
022-0222148-2139 - Terapijski učinak novosintetiziranih spojeva pri otrovanju organofosfatima (Lucić Vrdoljak, Ana, MZOS ) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Vesna Pavlica
(autor)
Aleksandra Fučić
(autor)
Ana Lucić Vrdoljak
(autor)
Božica Radić
(autor)
Snježana Ramić
(autor)
Marija Gamulin
(autor)
Mirta Milić
(autor)
Davor Želježić
(autor)
Nevenka Kopjar
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE